Comments
Loading...
Ovid Therapeutics (OVID) Forecast
NewsEarningsOvid Therapeutics (OVID) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOvid Therapeutics (NASDAQ:OVID) Stock Quotes, Forecast and News Summary
Ovid Therapeutics Stock (NASDAQ: OVID) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Ovid Therapeutics (OVID) stock?
You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.
Who are Ovid Therapeutics (OVID) competitors?
Other companies in Ovid Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR) and Gain Therapeutics (NASDAQ:GANX).
What is the forecast, or price target, for Ovid Therapeutics (OVID) stock?
Ovid Therapeutics has a consensus price target of $4.74.
What is the current price for Ovid Therapeutics (OVID)?
The stock price for Ovid Therapeutics (NASDAQ: OVID) is $0.742767 last updated January 22, 2025 at 2:08 PM EST.
Does Ovid Therapeutics (OVID) pay a dividend?
There are no upcoming dividends for Ovid Therapeutics.
When is Ovid Therapeutics (NASDAQ:OVID) reporting earnings?
Ovid Therapeutics’s Q4 earnings are confirmed for Friday, March 7, 2025.
Is Ovid Therapeutics (OVID) going to split?
There is no upcoming split for Ovid Therapeutics.
What sector and industry does Ovid Therapeutics (OVID) operate in?
Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.